Compare PAHC & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAHC | SGML |
|---|---|---|
| Founded | 1946 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2014 | 2021 |
| Metric | PAHC | SGML |
|---|---|---|
| Price | $35.16 | $9.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $41.25 | $18.75 |
| AVG Volume (30 Days) | 211.6K | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 104.20 | N/A |
| EPS | ★ 2.43 | N/A |
| Revenue | ★ $833,350,000.00 | N/A |
| Revenue This Year | $17.03 | $272.11 |
| Revenue Next Year | $3.82 | $36.70 |
| P/E Ratio | $14.66 | ★ N/A |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $28.25 | $4.62 |
| 52 Week High | $60.08 | $24.48 |
| Indicator | PAHC | SGML |
|---|---|---|
| Relative Strength Index (RSI) | 47.65 | 31.77 |
| Support Level | $30.55 | N/A |
| Resistance Level | $37.92 | $13.22 |
| Average True Range (ATR) | 1.60 | 0.63 |
| MACD | -0.25 | -0.38 |
| Stochastic Oscillator | 16.49 | 0.00 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds full interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil. Geographically, the company operates in Switzerland; United Arab Emirates; Singapore; and Republic of Korea, of which it derives maximum revenue from Switzerland.